Publications by authors named "Mark Ringhoffer"

Claim this Profile
D
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy.
Wolfgang Bethge, Sarah Flossdorf, Franziska Hanke, Christoph Schmid, Mark Ringhoffer

Haematologica· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Matjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, Linda Koster, Frantisek Folber, Mark Ringhoffer

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany.
Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantation.
Elisa Maria Amann, Sowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, Elisa Sala, Mark Ringhoffer

HLA· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.
Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, Johannes Krisam, Martin Görner, Mark Ringhoffer

Trials· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell Transplantation.
Sowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Mark Ringhoffer

Transplant Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W M Kühn, Mark Ringhoffer

Lancet Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
Maria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, Brigitte Neuber, Alexander Kunz, Mark Ringhoffer

J Hematol Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study.
Christine Neuchel, Sowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, Elisa Sala, Mark Ringhoffer

HLA· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation.
Chrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Mark Ringhoffer

Bone Marrow Transplant· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Mark Ringhoffer

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation.
Chrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Mark Ringhoffer

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
Daphne Mytilineos, Chrysanthi Tsamadou, Christine Neuchel, Uwe Platzbecker, Donald Bunjes, Mark Ringhoffer

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT.
Nico Gagelmann, Diderik-Jan Eikema, Liesbeth C de Wreede, Alessandro Rambaldi, Simona Iacobelli, Mark Ringhoffer

Bone Marrow Transplant· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML).
Mridul Agrawal, Peggy Schwarz, Benedetto Daniele Giaimo, Ivan Bedzhov, Andrea Corbacioglu, Mark Ringhoffer

Leukemia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte transfusions - bridging to allogeneic hematopoietic stem cell transplantation.
Thanh Mai Nguyen, Katrina Scholl, Irina Idler, Verena Wais, Sixten Körper, Mark Ringhoffer

Leuk Lymphoma· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Frank G Rücker, Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp-Schwoerer, Mark Ringhoffer

Blood· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with -ITD.
Richard F Schlenk, Daniela Weber, Walter Fiedler, Helmut R Salih, Gerald Wulf, Mark Ringhoffer

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Peter Paschka, Richard F Schlenk, Daniela Weber, Axel Benner, Lars Bullinger, Mark Ringhoffer

Leukemia· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.
Gwendolyn van Gorkom, Herve Finel, Sebastian Giebel, David Pohlreich, Avichai Shimoni, Mark Ringhoffer

J Clin Apher· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.
Daniel Fuerst, Christine Neuchel, Dietger Niederwieser, Donald Bunjes, Martin Gramatzki, Mark Ringhoffer

Blood· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.
Thomas Schroeder, Elena Rachlis, Gesine Bug, Matthias Stelljes, Stefan Klein, Mark Ringhoffer

Biol Blood Marrow Transplant· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group.
Peter Paschka, Richard F Schlenk, Verena I Gaidzik, Julia K Herzig, Teresa Aulitzky, Mark Ringhoffer

Haematologica· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.
Richard F Schlenk, Sabine Kayser, Lars Bullinger, Guido Kobbe, Jochen Casper, Mark Ringhoffer

Blood· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Michela Tassara, Konstanze Döhner, Peter Brossart, Gerhard Held, Katharina Götze, Mark Ringhoffer

Blood· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis